PubMed · 2026

Efficacy and safety of CBL-514 for Dercum disease lipomas: A randomized phase 2a study

Herbst KL, Ling YF, Sheu AY, Schlessinger DI, et al. (2026). Efficacy and safety of CBL-514 for Dercum disease lipomas: A randomized phase 2a study. JAAD International.

JAAD International

Source: https://pubmed.ncbi.nlm.nih.gov/41623934/

Last reviewed . By the PeptIQ team.

Peptides linked in PeptIQ Wiki

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.